Offer - Urjas Oil for just ₹ 1 X
Melanocyl Ointment, a prescription drug, is manufactured in various forms such as Ointment. Cutaneous T-Cell Lymphomas are some of its major therapeutic uses. The alternative uses of Melanocyl Ointment have also been explained below.
The right dosage of Melanocyl Ointment depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
Melanocyl Ointment also has some side effects, the most common being Skin redness, Blisters on skin. Some other side effects of Melanocyl Ointment have been listed ahead. Normally, these side effects of Melanocyl Ointment are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Melanocyl Ointment is Unknown for pregnant women and Unknown for women who are breastfeeding. Further, the section on Melanocyl Ointment related warnings talks about Melanocyl Ointment's effects on the liver, heart and kidney.
Individuals suffering from medical conditions like Porphyria, Xeroderma Pigmentosum, Skin Cancer must refrain from the use of Melanocyl Ointment since this can cause severe adverse effects. Other conditions have been mentioned below in the Melanocyl Ointment contraindications section.
Drug reaction of Melanocyl Ointment with other medicines has been reported. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Melanocyl Ointment is considered safe while driving, and is addictive.
Melanocyl Ointment is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Melanocyl Ointment safe for pregnant women?
Melanocyl Ointment can have harmful effects in pregnant women. If you experience any discomfort after using Melanocyl Ointment, then discontinue the use and take your doctor's advice.
Is the use of Melanocyl Ointment safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Melanocyl Ointment. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Melanocyl Ointment on the Kidneys?
Melanocyl Ointment rarely harms the kidneys.
What is the effect of Melanocyl Ointment on the Liver?
The liver can be affected by Melanocyl Ointment. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Melanocyl Ointment only after medical advice.
What is the effect of Melanocyl Ointment on the Heart?
Melanocyl Ointment may have mild side effects on the heart. Most people will never see any effect on the heart.
Melanocyl Ointment should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Melanocyl Ointment unless your doctor advises you to do so -
Is this Melanocyl Ointment habit forming or addictive?
Forming a habit of Melanocyl Ointment has not been reported.
Interaction between Food and Melanocyl Ointment
Due to the absence of research, it is difficult to say how Melanocyl Ointment and food will interact.
Interaction between Alcohol and Melanocyl Ointment
Due to lack of research, there is no information about the side effects of taking Melanocyl Ointment with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Uvadex® (methoxsalen)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 890-891